Research updates

  • Ph.D. Karlijn Bouman: understanding the progression of MDC1A

    Drs. Karlijn Bouman (PhD Candidate) is part of a team of Dutch doctors and researchers that are carrying out a natural history study for MDC1A patients. These studies aim to better understand how MDC1A progresses as a disease in patients overtime. Alongside Dr. Nicol Voermans, Dr. Corrie Erasmus and Dr. Jan Groothuis, drs. Karlijn Bouman…

    Read article
  • Dr. Carsten Bönnemann on MDC1A clinical trial readiness

    Dr. Carsten Bönnemann and Dr. Reghan Foley are running a natural history study for infants aged 0-5 years of age. This study is part of a wider effort to gain a better understanding of MDC1A and become ready for future clinical trials. Dr. Carsten Bönnemann and Dr. Reghan Foley are working on collecting data on…

    Read article
  • Dr. Avencia Sanchez-Mejías’ ex-vivo therapeutic approach to MDC1A

    Dr. Avencia Sanchez-Mejías has been investigating how haematopoietic stem cells from MDC1A patients’ bone marrow, can be genetically corrected to potentially improve quality of life. Dr. Avencia Sanchez-Mejías and her research team at the University of Pompeu Fabra in Barcelona have carried out a number of investigations focused on an ex-vivo therapeutic approach to MDC1A.…

    Read article